Aaron A Harthan1, Klayton W Buckley2, Margaret L Heger1, Randall S Fortuna3, Kyle Mays1. 1. Pharmacy Department, Children's Hospital of Illinois, Peoria, Illinois. 2. Perfusion Department, Children's Hospital of Illinois, Peoria, Illinois. 3. Department of Cardiothoracic Surgery, Children's Hospital of Illinois, Peoria, Illinois.
Abstract
OBJECTIVE: This study was conducted to evaluate the amount of medication adsorbed into extracorporeal membrane oxygenation (ECMO) circuits with a polymethylpentane membrane oxygenator and heparin-coated polyvinyl chloride tubing. METHODS: An ECMO circuit with the aforementioned components was set up ex vivo and primed with expired blood. Midazolam, lorazepam, morphine, and fentanyl were administered to the circuit. Fifteen minutes after medication administration, 60 mL of blood were removed and stored in a 60-mL syringe to serve as a control. Medication levels were drawn from the ECMO circuit (test) and control syringe (control) 15 minutes, 24 hours, and 48 hours after the medications were administered. ECMO circuit medication levels were compared to their corresponding syringe control medication levels. Descriptive statistics were used to determine the percentage of medication remaining in the blood and compare it to the control value. RESULTS: Except for morphine, there was a large decline in medication levels over the 48-hour period. Compared to control values, 17.2% of midazolam, 41.3% of lorazepam, 32.6% of fentanyl, and 102% of morphine remained in the ECMO circuit. CONCLUSION: Despite the use of newer components in ECMO circuits, a large quantity of medication is adsorbed into the ECMO circuit. Midazolam, lorazepam, and fentanyl all showed reductions in medication levels greater than 50%. Morphine may have advantages for patients on ECMO, as its concentration does not appear to be affected.
OBJECTIVE: This study was conducted to evaluate the amount of medication adsorbed into extracorporeal membrane oxygenation (ECMO) circuits with a polymethylpentane membrane oxygenator and heparin-coated polyvinyl chloride tubing. METHODS: An ECMO circuit with the aforementioned components was set up ex vivo and primed with expired blood. Midazolam, lorazepam, morphine, and fentanyl were administered to the circuit. Fifteen minutes after medication administration, 60 mL of blood were removed and stored in a 60-mL syringe to serve as a control. Medication levels were drawn from the ECMO circuit (test) and control syringe (control) 15 minutes, 24 hours, and 48 hours after the medications were administered. ECMO circuit medication levels were compared to their corresponding syringe control medication levels. Descriptive statistics were used to determine the percentage of medication remaining in the blood and compare it to the control value. RESULTS: Except for morphine, there was a large decline in medication levels over the 48-hour period. Compared to control values, 17.2% of midazolam, 41.3% of lorazepam, 32.6% of fentanyl, and 102% of morphine remained in the ECMO circuit. CONCLUSION: Despite the use of newer components in ECMO circuits, a large quantity of medication is adsorbed into the ECMO circuit. Midazolam, lorazepam, and fentanyl all showed reductions in medication levels greater than 50%. Morphine may have advantages for patients on ECMO, as its concentration does not appear to be affected.
Authors: Nilesh M Mehta; David R Halwick; Brenda L Dodson; John E Thompson; John H Arnold Journal: Intensive Care Med Date: 2007-04-03 Impact factor: 17.440
Authors: Christoph Wiesenack; Gunther Wiesner; Cornelius Keyl; Michael Gruber; Alois Philipp; Markus Ritzka; Christopher Prasser; Kai Taeger Journal: Anesthesiology Date: 2002-07 Impact factor: 7.892
Authors: Kiran Shekar; Jason A Roberts; Charles I Mcdonald; Stephanie Fisquet; Adrian G Barnett; Daniel V Mullany; Sussan Ghassabian; Steven C Wallis; Yoke L Fung; Maree T Smith; John F Fraser Journal: Crit Care Date: 2012-10-15 Impact factor: 9.097
Authors: Jennifer Sherwin; Elizabeth Thompson; Kevin D Hill; Kevin Watt; Andrew J Lodge; Daniel Gonzalez; Christoph P Hornik Journal: Cardiol Young Date: 2018-07-11 Impact factor: 1.093
Authors: Kevin M Watt; Michael Cohen-Wolkowiez; Duane C Williams; Desiree K Bonadonna; Ira M Cheifetz; Dhiren Thakker; Daniel K Benjamin; Kim L R Brouwer Journal: J Extra Corpor Technol Date: 2017-09